TP53 deletion elevated NEK2 expression by inducing NEK2 amplification, thereby inhibiting the ability of proliferation, drug resistance development, and tumorigenesis of multiple myeloma cells [26]. The gene discussed is NEK2; the disease is AL amyloidosis.